| Ytd | -6.21% | |
| 1y | -32.63% |
| Open | 1.45 | Prev Close | 1.46 | Low | 1.43 | High | 1.50 | Mkt Cap | 16.90M |
| Vol | 129.40K | Avg Vol | 921.59K | EPS | -3.02 | P/E | N/A | Forward P/E | -0.41 |
| Beta | 2.38 | Short Ratio | 3.81 | Inst. Own | 12.81% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 1.34 | 200-d Avg | 1.27 | 1yr Est | 1.00 |
BNGO News
SAN DIEGO, Sept. 23, 2026 (GLOBE NEWSWIRE) -- Bionano Laboratories, a wholly-owned subsidiary of Bio
Gainers Tempest Therapeutics (NASDAQ:TPST) stock increased by 41.6% to $1.07 during Tuesday's a
Bionano Genomics is surging Tuesday as investors weigh its growth strategy and favorable milestones
Gainers PDS Biotechnology (NASDAQ:PDSB) shares rose 63.7% to $0.65 during Tuesday's regular ses
Bionano Genomics, Inc. (NASDAQ:BNGO) today highlighted three new independently authored, peer-review
Independent research teams at MD Anderson Cancer Center, the University of Oulu, and the Josep Carre
Bionano Laboratories, a wholly-owned subsidiary of Bionano Genomics, Inc. (NASDAQ:BNGO) that offers
SAN DIEGO, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Bionano Laboratories, a wholly-owned subsidiary of Bio
New York State Department of Health approval allows clinical use of optical genome mapping (OGM) bas
SAN DIEGO, Aug. 24, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced t
Bionano Genomics, Inc. (BNGO) Q2 2026 Earnings Call Transcript
Bionano Genomics (NASDAQ:BNGO) raises FY2026 sales outlook from $30.000 million-$33.000 million to $
SAN DIEGO, July 27, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced t
SAN DIEGO, June 24, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a leader in geno
SAN DIEGO, June 18, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced t
SAN DIEGO, June 11, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced that to
Bionano Genomics (BNGO) might move higher on growing optimism about its earnings prospects, which is
Bionano Genomics (BNGO) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a
SAN DIEGO, May 28, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced th
SAN DIEGO, May 26, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced pu
Bionano Genomics, Inc. (BNGO) Q1 2026 Earnings Call Transcript
Bionano Genomics, Inc. (BNGO) came out with a quarterly loss of $0.76 per share versus the Zacks Con
Bionano Genomics (NASDAQ:BNGO) reported quarterly losses of $(0.76) per share which beat the analyst
Bionano Genomics (NASDAQ:BNGO) affirms FY2026 sales outlook from $30.000 million-$33.000 million to
SAN DIEGO, May 13, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported fin
$400,000,000Common StockPreferred StockDebt SecuritiesWarrantsUnitsFrom time to time, we may offer a
Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Al Luderer, Ph.D., chairman of Bionano
SAN DIEGO, May 06, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced th
Overall, studies show: OGM Can Resolve Previously Unresolved Rare Disease Cases OGM Can Serve as a G
SAN DIEGO, April 29, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced
HC Wainwright & Co. analyst Yi Chen maintains Bionano Genomics (NASDAQ:BNGO) with a Buy and l
Bionano Genomics stock soared on Monday as investors anticipated the company's Q4 earnings repor
The CNN Fear & Greed Index increased due to ongoing conflicts. U.S. stocks closed lower, with Na
US stock futures down, Caledonia Mining, United Airlines & Agi to report earnings, Cheetah Net &
Bionano Genomics, Inc. (BNGO) will release Q4 earnings on March 23. Analysts expect $1.40 loss per s
Bionano Genomics participated in the 2026 American College of Medical Genetics and Genomics Annual M
Bionano Genomics, Inc. (Nasdaq: BNGO) announced a peer-reviewed study published in Molecular Therapy
Bionano Laboratories, a wholly-owned subsidiary of Bionano Genomics, Inc. (NASDAQ:BNGO) offering CLI
HC Wainwright & Co. analyst Yi Chen maintains Bionano Genomics (NASDAQ:BNGO) with a Buy and l
Bionano Genomics (NASDAQ:BNGO) affirms FY2025 sales outlook from $26.000 million-$30.000 million to
Bionano Genomics (NASDAQ:BNGO) reported quarterly losses of $(1.59) per share which beat the analyst
Bionano Genomics (NASDAQ:BNGO) reported quarterly sales of $7.367 million which beat the analyst con
Bionano Genomics, Inc. (NASDAQ:BNGO) today announced the publication of a study in Cancers from The
Bionano Genomics, Inc. (NASDAQ:BNGO) participated in The American Society of Human Genetics (ASHG) c
